APPLICATION
ANDA076048
TYPE
ANDA
ORIGINAL APPROVAL
2007-10-22
LATEST ACTION
2023-07-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED REL PELLETS
MARKETING STATUS
Prescription
Products
OMEPRAZOLEPrescription
OMEPRAZOLE 20MG · CAPSULE, DELAYED REL PELLETS · ORAL
OMEPRAZOLEPrescription
OMEPRAZOLE 40MG · CAPSULE, DELAYED REL PELLETS · ORAL
OMEPRAZOLEPrescription
OMEPRAZOLE 10MG · CAPSULE, DELAYED REL PELLETS · ORAL
Approval history
2023-07-18Labeling · Supplement 29 · standardAP
2022-03-04Labeling · Supplement 28 · standardAP
2022-02-28Labeling · Supplement 26 · standardAP
2020-11-27Labeling · Supplement 23 · standardAP
2018-06-07Labeling · Supplement 21 · standardAP
2018-05-31Labeling · Supplement 20 · standardAP
2015-03-20Labeling · Supplement 19 · standardAP
2014-12-12Labeling · Supplement 17 · standardAP
2014-12-12Labeling · Supplement 16 · standardAP
2013-06-30Labeling · Supplement 11 · standardAP
2013-06-30Labeling · Supplement 12 · standardAP
2012-03-23Labeling · Supplement 9AP
2012-03-23Labeling · Supplement 7AP
2009-01-21Labeling · Supplement 3AP
2007-10-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.